Prof Bell is a Medical Oncologist in Sydney. He is a clinical lecturer at University of Sydney and works as a consultant oncologist and visiting specialist in several hospitals and private clinics. 

AWARDS:
• Edward Christie Stevens Fellowship, University of Toronto
       Awarded July 1983
• N.S.W. State Cancer Council Clinical Fellowship,
       Awarded October 1983
• Terry Fox Postdoctoral Fellowship,
       National Cancer Institute of Canada.
       Awarded March 1984
• Medal of the Order of Australia
      Awarded Queen’s Birthday Honours June 2020
 
MEDICAL LICENCES:
Medical Board of N.S.W                                            1977 - present
 
PROFESSIONAL BODIES:
Fellow, Royal Australasian College of Physicians.
Member, American Society of Clinical Oncology.
Member, Clinical Oncological Society of Australia.
Member, Medical Oncology Group of Australia.
Member, Cancer Research Group of COSA.
Member, ANZ Breast Cancer Clinical Trials Group.
 
ADMINISTRATIVE EXPERIENCE:
1. Member, Royal North Shore Hospital Drug Committee       1987 - 2000
2. Member, Specialist Advisory Committee of the Royal        1992 - 1999
    Australasian College of Physicians in Medical Oncology
3. Treasurer, Medical Oncology Group of Australia                1990 - 1999
4. Chairman, N.S.W. Co-operative Oncology Group                1993 - 1998
5. Secretary, N.S.W. Co-operative Oncology Group                1998 - 2000
6. Member, Board of Directors, Hope Healthcare Group         1994 -2004
7. Chairman, Medical Advisory Committee,                            2012 - present
    Northern Cancer Institute, Frenchs Forest.
8. Member of Council, The Scots College                              2019 - present
 
 
MEDICAL APPOINTMENTS (current):
Visiting Medical Oncologist,                                       October 1993 - present
Mater Misericordiae Hospital,
Crows Nest
 
Clinical Senior Lecturer in Medicine,                           October 1993 - present
University of Sydney
 
Visiting Specialist in Medical Oncology                     November 1994 - March 1997
Port Macquarie Base Hospital
 
Visiting Medical Practitioner                                      November 1995 to present
Consultant in Haematology/Oncology
Neringah Hospital
Wahroonga
 
Visiting Medical Oncologist,                                      July 1998 to present
North Shore Private Hospital,
St Leonards
 
Consultant Medical Oncologist,                                July 1998 to present
Northern Cancer Institute,
St Leonards, Frenchs Forest
 
CLINICAL AND TEACHING EXPERIENCE
1. Royal North Shore Hospital (Sydney) January 1980 - 1982.

• Primary care responsibility for the Medical Oncology Unit (average 40 beds). Malignancies include breast, lung, colon and rectum, sarcomas, testicular, renal, head and neck, malignant melanoma, lymphoma and brain tumours.

• Postgraduate teaching tutorials and lectures in Oncology to medical residents, registrars and specialist medical staff.

• Postgraduate teaching in general medicine for medical residents in preparation for Part One Royal Australasian College of Physicians Examination.

• Undergraduate teaching in physical diagnosis in general medicine Oncology lectures to nursing and social sciences personnel

2. Princess Margaret Hospital (Toronto, Canada) - 1983 - 1985.

• Management of patients with broad range of malignancies including leukaemia, lymphoma, small cell lung cancer, breast, testicular, myeloma, melanoma and ovarian.

• Postgraduate lectures to medical residents and specialist medical staff in Medical Oncology.

• Seminars to medical and scientific staff on multidrug resistance

3. Royal North Shore Hospital (Sydney) 1985 - 2015

• Staff Specialist in Medical Oncology with responsibility for Medical Oncology Unit (average 40 beds). Malignancies include breast, lung, colon and rectum, testicular, sarcoma, renal, melanoma, lymphoma, head and neck and brain.

• Undergraduate and postgraduate teaching in Medical Oncology and general medicine, University of Sydney.

4. Northern Cancer Institute (St Leonards and Frenchs Forest)  2012 - present

• Responsibility for patient management of a combined day care unit of approximately 35 beds, treating a range a malignancies with a particular focus on breast cancer, lung cancer, prostate cancer and colorectal cancer.

• Undergraduate and postgraduate teaching in Medical Oncology and general medicine, University of Sydney.
   

NATIONAL AND INTERNATIONAL PRESENTATIONS
Dr David Bell has given over 40 National and International presentations at various Oncology Meetings.
 
PUBLICATIONS
Dr David Bell has over 70 publications in peer-reviewed national and international medical journals.

Prof. Pachmann started her scientific career with the help of an Educational grant from the German Research Foundation (Deutsche Forschungsgemeinschaft) in 1974 at the Institute for Cell Research (Institutet för Cellforskning) Karolinska Institute Stockholm Sweden followed by a Research grant from the German Research Foundation (1976-1977) at the Institute for Hematology GSF (now Helmholtz Zentrum München). She was subsequently a Research Fellow at the Institute for Hematology GSF (now Helmholtz Zentrum München) from 1977 to 1982 followed by positions at the Klinikum rechts der Isar, Munich and Klinikum Innenstadt der Ludwig-Maximilians Universität, Munich. From 1996 to 1998 she was visiting scientist at the MD Anderson Cancer Center Houston Texas Section of Molecular Hematology and Therapy followed by 12 years as a Professor for Experimental Hematology and Oncology at the University of Jena.

Since 2012 she has been responsible for research at the Transfusion Center Bayreuth, Germany. Her key discoveries are the detection, quantitative determination and characterisation of tumour cells disseminated from solid tumours into the peripheral blood. The response of these cells to therapy correlates with clinical outcome and recently the possibility to clonally expand stem-like cells from these tumour cells circulating in the blood has been explored.

Initially, Ian studied the first two years of the Pharmacy course at the Victorian College of Pharmacy before completing tertiary qualifications in Biochemistry, Microbiology and Genetics at RMIT. Ian then became interested in medical research and completed a BSc (Hon.) degree, followed by a Doctorate (into the Biochemistry of connective tissue, especially proteoglycans and collagen) at Monash University. This study involved research into arthritis and ageing. He then joined his father, Dr Glen Dettman, at their family business, Oakleigh Pathology Service. Over the course of fifteen years he gained extensive hands-on experience in biochemistry, microbiology and haematology. In the latter years, Ian managed the pathology and helped it gain NATA accreditation. Ian became a Registered Pathology Practitioner. During the course of this 15 years (1973-1988), Ian became involved in Vitamin C research with Dr Glen Dettman and Dr Archie Kalokerinos. This research continues to this day. He personally developed patents concerning the manufacture of Vitamin C and extended his knowledge of nutrition, diet and lifestyle by becoming qualified as a Natural Therapist, in which he has continued to practise for the last 20 years. Ian also became a governor of the prestigious Southern School of Natural Therapies, where he sat on numerous committee meetings concerned with course content and natural therapies registration. Ian has lectured to Doctors, tutored in Biochemistry to medical students at Monash University, and lectured to students at the Southern School of Natural Therapies. He has co-authored numerous papers as well as the book Vitamin C - Nature’s Miraculous Healing Missile with his father Dr Glen Dettman, and Dr Archie Kalokerinos.

Ian was privileged and honoured to meet Professor Linus Pauling (the only person to have won two unshared Nobel prizes) at his home in Big Sur, California in November 1993. Ian and Glen received a grant from the Linus Pauling Institute for a research project to test Vitamin C levels on newborn babies delivered at a Community Hospital. Results were published in The Australian Nurses Journal.

Dr Ross Grant is a biochemical pharmacologist and Clinical Associate Professor at the University of Sydney, Medical School, and CEO of the Australasian Research Institute at Sydney Adventist Hospital. Dr Grant’s research focusses on understanding how a person’s range of Lifestyle factors changes their body’s biochemistry and immune activity driving it toward either health or disease.  In particular the influence of the constellation of lifestyle factors on natural killer (NK) cell activity, redox balance (i.e. oxidative stress) and NAD+ metabolism and how these influence cellular degeneration, particularly in the brain and central nervous system.

Medical Education:
Medical School, Tuzla University,
Bosnia and Herzegovina, MD

Licensure:

• Licensed Physician in Bosnia Herzegovina, 1990

• Licensed Physician in Germany, 1998

Board Certificated Specialty:

• Internal Medicine, Medical Chamber Westfalen-Lippe, Germany

• Medical Oncology & Hematology, Medical Chamber Westfalen-Lippe, Germany

• Gastroenterology, Medical Chamber Westfalen-Lippe, Germany

Internship & Residency:

• Medical Health Centre, Teslic, Bosnia and Herzegovina

• Specialized clinic for Internal medicine, Hematology and Oncology, Germany –Kornwestheim, Germany

• University Clinic Marienhospital der Ruhr – Bochum University, Germany Internal Medicine, Hematology & Oncology

• Johanneshospital – Dortmund, Germany, Gastroenterology

• University Center Tuzla, Bosnia and Hercegovina, Gastroenterology

Professional Expertise and Experience:

• Chief Physician in the Private Oncology Clinic, Leonardis, Germany – Bad Heilbrunn 01/2007 – 12/2008

• Director of the Clinic for Oncology, Hematology and Radiotherapy and Chief Physician for bone marrow transplantation at University Clinical Centre, Tuzla, Bosnia and Hercegovina 01/2009 – 12/2011

• Chief Physician in the Private Oncology Clinic Hallwang, Germany-Dornstetten-Hallwangen 01/2012 – 03/2014

• Chief physician in Private Oncology Daily Clinic in Stuttgart, Since 01/04/2014

Membership:
Medical Chamber, Badenwürttemberg, Germany

Advanced Training Courses:

• Ultrasound in Internal Medicine, Basic and advanced Traning Course, University Clinic Freiburg, Germany

• Gastrointestinal Endoscopy Traning Course, Bad Cannstatt Clinic, Stuttgart, Germany

• Colonoscopy Endoscopy Traning Course, Bad Cannstatt Clinic, Stuttgart, Germany

• Specialist Expertise in Radiation Protection, Medical Chamber Westfalen Lippe, Münster, Germany

• Specialist Expertise in Emergency Service, Medical Chamber Baden Wuerttemberg, Stuttgart, Germany

• Specialist certification for bronchoscopy, Doctors chamber Westfalen Lippe, Münster, Germany

• Specialist certification for Doppler Echocardiography, Reutlingen Hospital, Germany

• Basic and advanced training in Vascular Ultrasound (Doppler and Duplex Sonography) University Clinic Esslingen and University Clinic Würzburg, Germany

• Introductory training in Intensive Medicine, Arnsberg Hospital, Germany

• Hematological Cytology Basic and Advanced Training Course, Eschweiler Hospital, Germany

• Intensive Course in Internal Medicine, University Clinic Münster, Germany

• Psychosomatic Care, Basic Training Course, Medical Chamber Baden Württemberg, Stuttgart, Germany

Foreign Languages: German, English, Bosnian / Croatian / Serbian, Russian

Corporate Medical Director of HalioDx, Marjane Le Bagousse is a physician also graduated in healthcare administration in business school, trained in clinical research with >20 years of experience including hospital clinical practice, research management in cancer and industry medical & scientific senior positions background. Through wide coverage international firms, she has initially worked as auditor and management advisor for a number of payors, policy makers and groups of hospitals before extending to senior program officer role in National Cancer Institute in France.

Dr Le Bagousse owns a subject matter expertise in Compliance notably in new regulation conformity, for evidence supported market access.

In HalioDx she interacts with the medical and scientific community in variety of territories and represents the company in international meetings (i.e. ASCO, WCGI, ESMO Asia). As the senior medical director, interface to the field partners, she provides seminars, data support, training, and collaborative projects structure.

Luis Vitetta is Director of Medical Research at Medlab and Adjunct Professor at the University of Sydney, Sydney Medical School.

Luis's expertise includes probiotics, the human biome, nutraceuticals, nutrition, clinical trials, epidemiology', integrative and complementary medicine.

Between 2007-2013 Luis was the Director and Associate Professor of the Centre for Integrative Clinical and Molecular Medicine at The University of Queensland, School of Medicine. Luis is an Honours Graduate from Monash University (1981) in the Department of Biochemistry - Faculty of Medicine, and a PhD Graduate from the University of Melbourne Faculty of Medicine's Department of Surgery (1985) where he studied the epidemiological and aetiological factors of biliary disease. He has also studied medicine at the National University of La Plata Medical School in his native Argentina.

Luis was the chief investigator and the recipient of a National Institute of Complementary Medicine grant for the NICM Collaborative Centre for Transitional/Preclinical and Clinical Research in Nutraceuticals and Herbal Medicines.

Luis was a Senior Research Fellow at the Centre for Molecular Biology and Medicine, Epworth Medical Centre in Melbourne.

Between the years of 2000-2005 Luis was the Deputy Head and Director of Research of the Graduate School of Integrative Medicine at Swinburne University, where he assisted in implementing post graduate courses for medical graduates in the areas of nutrition and environmental medicine and integrative medicine. He has served as a member of the Cancer Council's epidemiology group, has been an alternate director of the Victorian Public Health Research and Education Council and a member of its research committee. He was a member of the executive board of the Australian Research Centre for Complementary and Alternative Medicine. He was also an honorary affiliate with the Department of Medicine, Nursing and Health Sciences, Monash University.

Earlier appointments include Senior Research Associate with the University of Melbourne's Faculty of Medicine - Centre for Palliative Care at Caritas Christi Hospice and St Vincent's Hospital and a University of Melbourne Research Fellow with the Faculty of Medicine and the Department of Surgery at the Austin and Repatriation Medical Centre.

Professor Vitetta has research interests in nutrition, functional foods and immune function, as well as Mind Body Medicine. He was the first internationally funded Australian researcher investigating Chinese Herbal Medicines in a trial with HIV patients. He is frequently invited to speak at local and international conferences.

Born: 23.02.1953 in Bad Homburg, Germany

Urologist
Oncologist
Conventionel and Biological Cancer Therapy
Photodynamic Tumor Therapy

Education

1978 – 1984 Study of Medicine Frankfurt / Main

1984 – 1990 Training in Urology, Municipal Hospital Offenbach / Main, Germany

1990 Fellowship MD Anderson Cancer Hospital Houston, Texas, USA

1990 – 1992 Head Physician Dept. of Urology Offenbach/Main, Germany

1992 – 2000 Private Clinic for Urology, Friedrichsdorf, Germany

2001 – 2002 Head of Urology Dept., Cancer Hospital St. Georg, Bad Aibling, Germany

2003 Private Clinic for Complementary Urology, Oncology , Immunotherapy, Lasertherapy

Consultant of national and international Cancer Centers, Rome, Verone, Vancouver, Sydney, Bangkok, Tel Aviv, Vienna

Research and development of biologic based preparations for therapies of tumor diseases in cooperation with Burg-Pharmacy, Königstein/ Germany.

Michael is a PhD scholar at the University of Sydney, Sydney Medical School in the Discipline of Pharmacology and is affiliated with Medlab Clinical.

He has a Master’s degree in Applied Science and has been practicing as a naturopath and herbalist for 30 years, specialising in cancer support utilising nutritional and herbal medicines and the supply of hyperthermia devices for cancer support.

Michael is researching chemoradiotherapy-induced mucositis, intestinal dysbiosis and the role of probiotics in preventing and or reducing chemotherapy/radiotherapy-induced diarrhoea in patients diagnosed with cancer.

My journey in professional  healthcare began over 30 years, with training that involved the medical background from nursing, to natural medicine and yoga.

My work includes the production of a deep relaxation CD, 'The Journey Home ', as well as, clinical duties and manufacturer of healthcare products. Currently I am working on my first book that discusses the; Be Aware TM holistic healthcare model, of which was conceived in 1992. 

My employment as a Holistic healthcare practitioner has included; private clinics and medical centres, and currently I am an academic lecturer at Endeavour College, along with my private practice clinic and a Private Detox Centre. My recent studies included 'Functional herbal therapy and cancer' by Professor  Kerry Bone,  of which has led to the schematic,  'A holistic molecular perspective of cancer development.'

On a personal note, the subject of cancer has been quite extensive, with my mother, her mother and her mother all acquiring breast cancer. Plus other  family members with cancer, and not forgetting my own case of melanoma and BCCs. Therefore, the study of cancer and health has assisted my understanding greatly, as I hope the schematic may assist with your healing treatment plan. 

1970-1978 Studied biology, doctoral thesis (Ph.D.) in biochemistry at the University of Göttingen, Germany

1975-1980 Studied medicine at the University of Göttingen, Germany

1979-1980 Max-Planck Institute for experimental medicine in Göttingen, Germany

1980-1981 Nuffield Laboratory of Ophthalmology in Oxford, England

1981-1983 Max-Planck Institute for experimental Medicine in Göttingen, Germany

1984-1990 Department of Gynecology and Obstetrics, University Hospital Göttingen, Germany

Head of the laboratory for tumor immunology

1990-1992 Senior physician at the Department of Gynecology and Obstetrics

since 1993 Founder of the Institute for Tumor Therapy in Duderstadt, Germany.

Active specific immunotherapy for cancer patients

since 1999 Dendritic cell therapy for patients suffering from various malignancies

2010 Founder of the Praxisgemeinschaft für Zelltherapie GmbH in Duderstadt, Germany

Immunotherapy for patients with neurodegenerative diseases (e.g. Alzheimer), degenerative diseases (e.g. peripheral arterial occlusive disease) and autoimmune diseases (e.g. scleroderma)

Dendritic cell therapy for patients suffering from various malignancies

since 2012 GMP-laboratory and personal manufacturer´s authorization for manufacturing cell therapy products certified by the authority

Dr Christine Houghton, an educator, research scientist and a registered nutritionist, holds degrees in Nutrigenomics, Biochemistry and Human Nutrition. An avid researcher in her field, she is Adjunct Lecturer in the School of Human Movement and Nutrition Science at the University of Queensland.

Following 3 decades in private Nutritional Medicine practice, Christine founded Cell-Logic, a evidence-focused company which researches and manufactures nutrigenomically-active ingredients for clinical application. Her current interests lie in the investigation of phytochemicals which significantly impact gene expression within human cells, especially in the context of gut ecology and immune modulation.

Sulforaphane, the bioactive phytochemical derived from certain cruciferous plants has been the primary focus of her phytochemical research, with three indexed review publications and two book chapters supporting her acknowledged role as an authority in this field.

Dr Barbara Fougere is an integrative veterinarian and teacher. She has a practice in Sydney, and founded a college in veterinary integrative therapies with students all around the world.  She has been a veterinary acupuncturist and herbalist for more than 30 years and has authored several text books.

She has a keen interest in integrative medicine for humans and the overlap between animals and humans. She was a finalist vet of the year and practice of the year one month before being diagnosed with breast cancer in late 2017.

Her focus now: metabolic control of breast cancer and circulating tumor cells.

Prof Vogl is an internationally acclaimed Interventional Radiologist, specialising in Cancer Patients.

Current position

Head of the Department of Diagnostic and Interventional Radiology
University Hospital Frankfurt

Section head including the sections pediatric radiology, interventional radiology, breast imaging, orthopedic radiology, vascular radiology

Education
1976-1982   Medical School, Ludwig Maximilian University in Munich
14.12.1982   Graduation from Ludwig Maximilian University Munich with M.D.            
                       
Scientific Career
01/83-07/88   Intern at the Department of Radiology, University Hospital Munich
Aug. 1988   Research Fellowship at the Massachusetts General Hospital Boston
10/88-03/90   Training in nuclear medicine
15.02.89   Qualified as „Specialist in Radiology“
01.01.90   Senior Consultant at the Department of Radiology, University Hospital Munich
01.03.92   Qualification in nuclear medicine
01.11.92   Assistant Medical Director at the Department of Radiation Therapy,  Free University Berlin, University Hospital Rudof Virchow
15.11.92   Professor of Radiology, Free University of Berlin
04/96   Qualification as Doctor for Neuroradiology
Since11/98   Head of the Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt
2007-2012   Vice Chairman, Board of Directors at the University Hospital Frankfurt    
2012-2020   Chairman of the Frankfurt clinic alliance (Klinikallianz)
Since 2013   Representative for guideline compliance of the German X-ray society

Co-founded EnGeneIC Pty Ltd in 2001 and built it from the concept stage to a company based in Australia and USA, a small scale manufacturing plant in Sydney and now a clinical stage biopharmaceutical company.

Dr Brahmbhatt co-invented the first-in-class, EDV (EnGeneIC Dream Vector) cyto-immunotherapeutic technology for the effective treatment for several different cancers. Safety and dramatic anti-tumor efficacy has been demonstrated in one each of end-stage mesothelioma, glioblastoma and pancreatic cancer patients.

The company is now in Phase IIa clinical trials in several cancers. The technology is globally unique and he is the co-inventor on over 419 granted patents world-wide with 74 additional patent applications pending.

The two co-founders have raised over $80 million to fund EnGeneIC’s development and operations.

He has a strong background in R & D innovation and the biopharmaceuticals business having successfully developed sophisticated investor base, company operations in Australia and USA, corporate governance, building business relationships with senior business development executives in Big Pharma companies in USA, Europe and Japan and building business relationships with major investment banks in USA.

He is the principal author on several scientific and clinical research papers including high impact publications in Cancer Cell, Nature Biotechnology and Lancet Oncology.

He has been awarded a number of national and international research grants. In 2007, ABC TV (Australian national TV channel)  produced an “Australian Story”, For the Holy Grail, on the motivation and efforts for H & J to build EnGeneIC and develop the EDV technology. It has become an Australian Story Classic and has been purchased by Foxtel for screening worldwide. The YouTube version can be viewed on EnGeneIC website

In 2009, BBC and independent documentary film maker, Rymer Childs commenced filming the EnGeneIC journey from research to the clinic to commercialization. This filming is on-going.

He graduated with an M.Sc. from the MS University (Baroda, India) and Ph.D from University of Adelaide (Australia). He did his post-doctoral research at the Geneva Medical Centre (Switzerland) and The National Centre for Research in Biotechnology (Germany).

Prior to founding EnGeneIC, he was the Principal Scientist at CSIRO.

Michael Jackson  is Director of Radiation Oncology at Prince of Wales Hospital in Sydney, a Conjoint Associate Professor at the University of New South Wales and a an Honorary Professorial Fellow, School of Engineering Physics, University of Wollongong.

He originally qualified in medicine in the UK and came to Australia via New Zealand in 1980. He trained as a radiation oncologist at the Peter MacCallum Cancer Institute in Melbourne and then worked in several Queensland centres, the ACT and Royal Prince Alfred Hospital before moving to Prince of Wales in 2008.

He has a long-standing interest in the use of new technology to improve the outcomes of radiotherapy.  He has been interested in hyperthermia for over 30 years and is working to introduce it into scientifically based combined modality therapy. This has the potential to improve the effectiveness and reduce the toxicity of radiotherapy, chemotherapy and immunotherapy.

Dr Mark Donohoe is one of Australia’s best-known practitioners of Integrative Medicine. He graduated from Sydney University 1980, he practised on the Central Coast New South Wales from 1983 until 1988. This led him into the fields of Environmental Medicine and Nutritional Medicine, and he was awarded fellowships from the Australian Society of Environmental Medicine (ASEM), the Australasian College of Nutritional & Environmental Medicine (ACNEM), and more recently the Australasian Society of Lifestyle Medicine (ASLM).

Over his 37 years in practice, Mark has specialised in the fields of chronic fatigue syndrome, environmental and occupational toxicology, and central sensory sensitivities including multiple chemical sensitivity and electro-hypersensitivity. He has numerous publications in the medical literature to his name, and has been active for decades in the education of doctors and complementary health practitioners.

Mark works with his wife, Fiona, at Mosman Integrative Medicine in Sydney. While he looks after the patients seeking the causes of their illnesses and diseases, Fiona heads up the healthcare side of the practice with natural healthcare practitioners and classes in yoga, Qigong, pregnancy yoga, meditation, mindfulness and movement.

Mark and Fiona work together with an underlying philosophy that health in all its forms is the best prevention of disease, and that most disease is best managed by clean air, clean food, clean water and a commitment to a lifestyle that is health enhancing.

Prof. Molodysky is a leading Australian medical educator, focused on translating research into day-to-day primary care clinical practice. He is a Clinical Associate Professor at the University of Sydney and a Visiting Medical Specialist, St Vincent’s Private Hospital. Prof. Molodysky has held a number of key positions, including: Member, Medical Board of New South Wales; Adjunct Associate Professor, School of Medicine, University of Notre Dame, President, Australasian College of Nutritional & Environmental Medicine; and Head, Asia-Pacific Economic Cooperation (APEC) Taskforce Medical Team, Office of the Prime Minister.

Current clinical applications of translational research being introduced by Professor Molodysky include epigenetic analysis and therapy (such as NAD+), and cell-based regenerative therapies (NKCs and MSCs). Prof. Molodysky is collaborating in a research project with A/Prof. Ross Grant of the Australasian Research Institute (ARI), and Prof. Katharina Pachmann of the Transfusion Medicine Centre Bayreuth in studying the relationship between NAD+, NKC activity and CTCs, in both health and disease.

Dr Joachim Fluhrer is a medical practitioner who is widely regarded as a leader in the field of integrative and personalised medicine.

His particular interest is personalised cancer management and the early adoption into clinical practice of evidence-based liquid biopsy and tumour profiling. He currently incorporates liquid biopsy into his own practice, sourcing the most advanced, sensitive, specific and clinically validated technology internationally and advocating for the technique through national and online seminars and practitioner education.

Dr Fluhrer is considered one of Australia’s most experienced practitioners and educators in combining nutritional and environmental medicine with standard medical practice. As a senior lecturer, he has presented at seminars and conferences nationally and internationally for more than 30 years.

His positions include member of the Cancer Research Network, Sydney University, Faculty Member of the Australasian College for Medical Nutrition, board member of the Australasian Integrative Medical Association, Vice-President of the Australian College for Nutritional and Environmental Medicine (1999-2007) and committee member of the Australian Pharmaceutical Advisory Council (2003-2004).